X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
12
PharmaCompass offers a list of Metoclopramide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metoclopramide manufacturer or Metoclopramide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metoclopramide manufacturer or Metoclopramide supplier.
PharmaCompass also assists you with knowing the Metoclopramide API Price utilized in the formulation of products. Metoclopramide API Price is not always fixed or binding as the Metoclopramide Price is obtained through a variety of data sources. The Metoclopramide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one, including repackagers and relabelers. The FDA regulates 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one supplier is an individual or a company that provides 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one active pharmaceutical ingredient (API) or 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one finished formulations upon request. The 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers may include 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one API manufacturers, exporters, distributors and traders.
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one active pharmaceutical ingredient (API) in detail. Different forms of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one DMFs exist exist since differing nations have different regulations, such as 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one DMF submitted to regulatory agencies in the US is known as a USDMF. 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one USDMF includes data on 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one Drug Master File in Japan (1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one JDMF) empowers 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one JDMF during the approval evaluation for pharmaceutical products. At the time of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one Drug Master File in Korea (1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one. The MFDS reviews the 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one KDMF as part of the drug registration process and uses the information provided in the 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one KDMF to evaluate the safety and efficacy of the drug.
After submitting a 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers with KDMF on PharmaCompass.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one written confirmation (1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one WC) is an official document issued by a regulatory agency to a 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one manufacturer, verifying that the manufacturing facility of a 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one APIs or 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one finished pharmaceutical products to another nation, regulatory agencies frequently require a 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one WC (written confirmation) as part of the regulatory process.
click here to find a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers with Written Confirmation (WC) on PharmaCompass.
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one GMP manufacturer or 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one GMP API supplier for your needs.
A 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one CoA (Certificate of Analysis) is a formal document that attests to 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one's compliance with 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one specifications and serves as a tool for batch-level quality control.
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one CoA mostly includes findings from lab analyses of a specific batch. For each 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one may be tested according to a variety of international standards, such as European Pharmacopoeia (1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one EP), 1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one USP).
Market Place
